2d:I[856015,["/_next/static/immutable/chunks/1xzisbplk9czp.js","/_next/static/immutable/chunks/3j2i1faptc_-9.js","/_next/static/immutable/chunks/0fma7nlq6immz.js","/_next/static/immutable/chunks/08tq8rmv423j5.js","/_next/static/immutable/chunks/1chr5wkk3j58k.js","/_next/static/immutable/chunks/37kmmh_zm4dov.js","/_next/static/immutable/chunks/311zvdjfxff-f.js","/_next/static/immutable/chunks/1a_hqhrsle_n_.js"],"default"] 2e:T54e3,

Summary Table

Category	Detail
Risk Factors	History of prior varicella (chickenpox) infection, immunocompromised states (HIV/AIDS, organ transplant recipients, chronic corticosteroid use), elderly patients (>60 years), unvaccinated individuals
Etiology	Reactivation of varicella-zoster virus (VZV) latent in the geniculate ganglion of cranial nerve VII (facial nerve)
Patient Presentation	Acute onset of severe ear pain (otalgia), followed by unilateral facial paralysis and vesicular rash in or around the ear
Classic Physical Exam	Vesicular eruption on the auricle, external auditory canal, and/or tympanic membrane ipsilateral to facial nerve palsy; may have sensorineural hearing loss, vertigo, tinnitus
Key Diagnostic Results	Clinical diagnosis; PCR of vesicle fluid for VZV DNA is confirmatory; audiometry may show sensorineural hearing loss; MRI may show enhancement of CN VII
Management	Acyclovir (or valacyclovir) + corticosteroids initiated within 72 hours of symptom onset
Keywords	"Ear pain with vesicles," "facial paralysis with ear rash," "vesicles on the auricle," "geniculate ganglion," "herpes zoster oticus"

1. Pathophysiology

Ramsay Hunt Syndrome results from the reactivation of varicella-zoster virus (VZV) that has remained dormant in the geniculate ganglion following a primary varicella infection, often decades earlier. The geniculate ganglion is the sensory ganglion of the facial nerve (CN VII), located within the temporal bone at the junction where the facial nerve makes its first sharp turn (the "genu" or knee of CN VII).

When the virus reactivates, it travels anterogradely along sensory fibers of CN VII. The nervus intermedius, the sensory root of CN VII, provides innervation to portions of the auricle, external auditory canal, and a small region of the tympanic membrane. This is why vesicles erupt in these anatomical distributions rather than along a typical dermatome. The viral inflammation and edema within the narrow fallopian canal (the bony canal housing the facial nerve through the temporal bone) directly compresses CN VII motor fibers, producing an ipsilateral lower motor neuron facial palsy that is clinically indistinguishable in pattern from Bell palsy.

Because the geniculate ganglion sits in close anatomical proximity to the vestibulocochlear nerve (CN VIII), viral spread or inflammatory edema can affect this neighboring structure. This explains why patients may develop sensorineural hearing loss, vertigo, nausea, and tinnitus, features that are not seen in isolated Bell palsy and serve as distinguishing findings on exam vignettes.

The prognosis of Ramsay Hunt Syndrome is notably worse than Bell palsy. Only about 50-70% of patients with Ramsay Hunt Syndrome achieve complete facial nerve recovery, compared to approximately 85-90% for Bell palsy. This is because the direct viral cytopathic effect on the nerve causes more severe axonal damage than the presumed immune-mediated inflammation of Bell palsy.

2. Classification and Clinical Manifestation

Classic Triad

Feature	Description
Ipsilateral facial paralysis	Lower motor neuron pattern (entire half of face affected, including forehead); onset may precede or follow the rash
Vesicular eruption	Grouped vesicles on an erythematous base involving the auricle (concha, antihelix), external auditory canal, and/or tympanic membrane
Otalgia	Severe, deep ear pain; often the earliest symptom and may precede rash by several days

Associated Features by Cranial Nerve Involvement

Structure Affected	Clinical Finding	Mechanism
CN VII motor fibers	Unilateral facial droop, inability to close eye, loss of forehead wrinkling	Viral inflammation compressing motor fibers in fallopian canal
CN VII sensory (chorda tympani)	Loss of taste on anterior two-thirds of the tongue (ageusia)	VZV affecting the nervus intermedius sensory branch
CN VIII (cochlear division)	Sensorineural hearing loss, tinnitus	Spread of inflammation to adjacent vestibulocochlear nerve
CN VIII (vestibular division)	Vertigo, nystagmus, nausea	Vestibular nerve involvement
CN V, IX, X (rare)	Facial or pharyngeal vesicles, dysphagia, hoarseness	Viral spread to adjacent ganglia

Staging by Severity

Grade	Description
Mild	Facial paresis (incomplete paralysis), vesicular rash, otalgia, no CN VIII involvement
Moderate	Complete facial paralysis, vesicular rash, mild hearing loss or tinnitus
Severe	Complete facial paralysis with vertigo, marked sensorineural hearing loss, and possible involvement of additional cranial nerves

A critical teaching point: "Zoster sine herpete" is a recognized variant where the patient develops facial paralysis and otalgia without visible vesicles. This is an extremely high-yield exam trap because the absence of rash may lead students to diagnose Bell palsy instead. PCR testing of saliva or middle ear fluid can confirm VZV reactivation in these cases.

3. Diagnostic Workup

Summary Table

Test	Role	Expected Finding
Clinical examination	Best initial diagnostic approach	Classic triad of vesicular rash + facial palsy + otalgia
VZV PCR (vesicle fluid, saliva)	Most accurate/confirmatory test	Positive VZV DNA
Tzanck smear	Rapid bedside test (low sensitivity)	Multinucleated giant cells (not VZV-distinguishing from HSV)
Direct fluorescent antibody (DFA)	Rapid and more precise than Tzanck	Identifies VZV antigens in vesicle scrapings
MRI with gadolinium	Adjunctive (not required for diagnosis)	Enhancement of CN VII, especially at the geniculate ganglion
Audiometry	Functional assessment	Sensorineural hearing loss pattern
Electroneuronography (ENoG)	Prognostic tool (not diagnostic)	Degree of nerve degeneration; performed 3-14 days after onset

Ramsay Hunt Syndrome is fundamentally a clinical diagnosis. When a patient presents with the classic triad of otalgia, ipsilateral facial paralysis, and vesicular eruption on the ear, no further testing is strictly required to establish the diagnosis. The vignette itself is the diagnostic test, and the exam is testing whether you can recognize this pattern.

However, when the presentation is atypical or the rash has not yet appeared, PCR of vesicle fluid (or saliva if vesicles are absent) is the most accurate confirmatory test. PCR detects VZV DNA with high sensitivity and can distinguish VZV from HSV, which is relevant because herpes simplex can occasionally produce a similar clinical picture.

Tzanck smear is a classic exam topic. Scraping the base of a vesicle reveals multinucleated giant cells, but this test cannot differentiate between VZV and HSV. It is rapid and inexpensive, making it a reasonable bedside test, but it is neither sensitive nor pathogen-distinguishing. Test-writers love asking what Tzanck smear shows and whether it can confirm VZV over HSV (it cannot).

MRI with gadolinium may demonstrate enhancement of the facial nerve at the level of the geniculate ganglion and within the fallopian canal. This is not routinely needed for diagnosis but may appear in vignettes asking about imaging findings or when the diagnosis is uncertain.

Audiometry should be obtained in all patients to document baseline hearing and to detect sensorineural hearing loss. This also has prognostic value.

4. Management and Treatment

Summary Table

Phase	Intervention	Details
Antiviral therapy	Valacyclovir 1000 mg PO three times daily x 7 days	Preferred due to better bioavailability; alternative: acyclovir 800 mg PO five times daily x 7-10 days; IV acyclovir 10 mg/kg every 8 hours for immunocompromised patients
Corticosteroids	Prednisone 1 mg/kg/day (max 60 mg) PO x 7 days, then taper over 7-14 days	Reduces inflammation and neural edema within the fallopian canal
Eye protection	Artificial tears, lubricating ointment, moisture chamber or taping eyelid shut at night	Prevents exposure keratopathy from incomplete eyelid closure (lagophthalmos)
Pain management	Analgesics (NSAIDs, gabapentin, or pregabalin for neuropathic pain)	Postherpetic neuralgia may require long-term neuropathic pain agents
Surgical decompression	Rarely considered; no strong evidence	Reserved for complete paralysis unresponsive to medical therapy; controversial

The cornerstone of treatment is combined antiviral therapy plus corticosteroids, and the critical teaching point is that both must be started within 72 hours of symptom onset for optimal outcomes. This time window appears frequently in exam questions.

Valacyclovir is generally preferred over acyclovir in the outpatient setting because its superior oral bioavailability allows less frequent dosing (three times daily versus five times daily), improving adherence. The antiviral agent works by inhibiting viral DNA polymerase after being phosphorylated by VZV thymidine kinase, limiting ongoing viral replication and neural destruction.

Corticosteroids are added to reduce the inflammatory edema within the rigid fallopian canal. Because the canal is a confined bony space, even modest swelling creates compression injury to the facial nerve. Prednisone is typically started at 1 mg/kg/day (maximum 60 mg/day) for 5-7 days, followed by a gradual taper over 1-2 weeks. There is ongoing debate about corticosteroid benefit in isolation, but the combination of antivirals plus corticosteroids has shown improved rates of facial nerve recovery compared to antivirals alone.

Eye care is a "next best step" concept that test-writers frequently include. Because facial nerve palsy prevents complete eyelid closure, the cornea is at risk for exposure keratopathy and even corneal ulceration. Every patient with facial paralysis should receive aggressive eye protection: artificial tears during the day, lubricating ointment at night, and taping the eyelid or using a moisture chamber during sleep.

For immunocompromised patients, intravenous acyclovir (10 mg/kg every 8 hours) is indicated due to the risk of disseminated zoster. Renal dosing adjustments are necessary for both acyclovir and valacyclovir, as these drugs are nephrotoxic and can cause crystalline nephropathy, particularly in dehydrated patients or those with pre-existing renal impairment.

Postherpetic neuralgia (persistent pain after rash resolution) may require long-term management with gabapentin (starting at 300 mg/day, titrated to 1800-3600 mg/day in divided doses), pregabalin, tricyclic antidepressants (amitriptyline 25-75 mg at bedtime), or topical lidocaine patches.

5. Differential Diagnosis and Distractors

Differential Diagnosis	Why It Is Similar	Key Discriminator
Bell palsy	Both cause acute unilateral lower motor neuron facial paralysis; Bell palsy is far more common	Bell palsy has no vesicular rash and no CN VIII symptoms (no hearing loss, no vertigo). If vesicles on the ear are present, it is Ramsay Hunt, not Bell palsy
Acute otitis externa	Both present with severe ear pain; external canal may appear erythematous and swollen	Otitis externa causes diffuse canal edema and otorrhea, not grouped vesicles. No facial paralysis is expected
Acute otitis media	Otalgia and possible CN VII involvement (if infection erodes into the fallopian canal)	Otitis media shows a bulging, erythematous tympanic membrane with conductive (not sensorineural) hearing loss. Vesicles are absent
HSV reactivation (herpes simplex)	HSV can occasionally affect the geniculate ganglion and produce a nearly identical syndrome	Clinically difficult to distinguish; PCR is needed to differentiate VZV from HSV. HSV-related facial palsy is much rarer
Cholesteatoma	Can cause facial nerve palsy and hearing loss due to erosion of the fallopian canal	Cholesteatoma produces conductive hearing loss (not sensorineural), chronic foul-smelling otorrhea, and white retrotympanic mass. No vesicles
Central stroke (UMN facial palsy)	Both involve facial weakness	Stroke causes upper motor neuron pattern: forehead is spared(bilateral cortical innervation). No vesicles, no otalgia. Other focal neurological deficits are typically present
Lyme disease	Can cause bilateral or unilateral facial nerve palsy	Look for history of tick exposure, erythema migrans rash(expanding target lesion on the body, not vesicles on the ear), arthralgias, and endemic geography

6. Traps and High-Yield Pearls

The most common way students get questions on Ramsay Hunt Syndrome wrong is by defaulting to a Bell palsy diagnosis whenever they see facial nerve palsy. Bell palsy is by far the more common condition, and because it is an "idiopathic" diagnosis of exclusion, students often anchor to it too quickly. The critical discriminator that test-writers embed in the stem is the presence of vesicles on or near the ear and/or CN VIII symptoms (hearing loss, vertigo). If either of these features appears in the vignette, Bell palsy is the wrong answer.

A second major trap involves zoster sine herpete, the variant where the vesicular rash is absent or has not yet appeared at the time of presentation. In these vignettes, the patient has facial paralysis, severe otalgia, and possibly auditory or vestibular symptoms, but no visible rash. The question may ask for the next best diagnostic step, and the answer is VZV PCR of saliva or vesicle fluid (if vesicles later appear).

A third high-yield concept is the timing of treatment. Antivirals and corticosteroids must be initiated within 72 hours to offer meaningful benefit. Vignettes testing management may present a patient who is 5 days into symptoms and ask whether antivirals are still indicated. The evidence for benefit beyond 72 hours is weak, but most guidelines still recommend treatment for immunocompromised patients regardless of timing.

Finally, never forget the eye protection question. A patient with facial palsy who cannot close the eyelid is at risk for corneal damage. If the question asks, "What is the most important supportive measure?" the answer involves protecting the cornea with artificial tears and nighttime taping, not simply prescribing antivirals.

The core competency being tested is pattern recognition: distinguishing Ramsay Hunt Syndrome from Bell palsy through the presence of vesicular eruption and CN VIII involvement, initiating combined antiviral-corticosteroid therapy within the treatment window, and understanding the anatomical basis for each clinical feature.

1e:["$","$L2d",null,{"article":{"id":"00b2c92e-ca98-4b18-99ee-3030bcb18d5a","title":"Ramsay-Hunt Syndrome","content":"$2e","category":"THT-KL","created_at":"2026-05-14T14:36:29.800843+00:00","status":"published","subcategory":null},"questionCount":1,"sections":[{"id":"section-pathophysiology","num":"01","title":"Pathophysiology"},{"id":"section-classification-and-clinical-manifestation","num":"02","title":"Classification and Clinical Manifestation"},{"id":"section-diagnostic-workup","num":"03","title":"Diagnostic Workup"},{"id":"section-management-and-treatment","num":"04","title":"Management and Treatment"},{"id":"section-differential-diagnosis-and-distractors","num":"05","title":"Differential Diagnosis and Distractors"},{"id":"section-traps-and-high-yield-pearls","num":"06","title":"Traps and High-Yield Pearls"}],"hasSummaryTable":true}]